Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.12% |
| 2 | Technology | 12.96% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11.23% |
| 5 | Consumer Staples | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRE
451
DELISTED
Veris Residential
VRE
| $37.1M | 0.06% |
1,279,900
+45,900
| +4% | +$1.23M |
|
452
Huazhu Hotels Group
HTHT
$12.9B
| $37M | 0.06% |
2,854,800
+283,200
| +11% | +$3.34M |
|
453
PetMed Express
PETS
$42.1M
| $36.9M | 0.06% |
1,597,700
+29,785
| +2% | +$638K |
|
454
OraSure Technologies
OSUR
$273M
| $36.9M | 0.06% |
4,197,303
+225,800
| +6% | +$1.86M |
|
455
Everest Group
EG
$15.4B
| $36.7M | 0.06% |
169,700
-101,000
| -37% | -$20.8M |
|
456
Pentair
PNR
$10.2B
| $36.7M | 0.06% |
+973,901
| New | +$38M |
|
457
KLA
KLAC
$266B
| $36.6M | 0.06% |
4,647,840
-8,581,000
| -65% | -$65.5M |
|
|
PINC
458
DELISTED
Premier
PINC
| $36.5M | 0.06% |
1,203,800
-371,900
| -24% | -$11.5M |
|
459
Carlisle Companies
CSL
$13.8B
| $36.5M | 0.06% |
331,200
+20,800
| +7% | +$2.27M |
|
|
FBR
460
DELISTED
Fibria Celulose Sa
FBR
| $36.5M | 0.06% |
3,800,800
-463,528
| -11% | -$3.9M |
|
|
NFBK
461
DELISTED
Northfield Bancorp
NFBK
| $36.5M | 0.06% |
1,827,068
+51,600
| +3% | +$925K |
|
462
Skywest
SKYW
$4.37B
| $36.2M | 0.06% |
994,100
+307,100
| +45% | +$10.3M |
|
463
Kilroy Realty
KRC
$4.58B
| $36.1M | 0.06% |
493,700
+286,600
| +138% | +$20.5M |
|
464
Snap-on
SNA
$21.1B
| $36.1M | 0.06% |
210,800
+157,700
| +297% | +$25.7M |
|
|
DMC
465
Del Monte Corp
DMC
$1.36B
| $36M | 0.06% |
594,500
+38,400
| +7% | +$2.36M |
|
466
Haemonetics
HAE
$3.63B
| $36M | 0.06% |
895,200
+11,600
| +1% | +$437K |
|
|
IPHS
467
DELISTED
Innophos Holdings, Inc.
IPHS
| $35.7M | 0.06% |
683,300
-16,196
| -2% | -$787K |
|
468
AB InBev
BUD
$156B
| $35.5M | 0.06% |
337,000
-344,717
| -51% | -$38.6M |
|
|
IPG
469
DELISTED
Interpublic Group of Companies
IPG
| $35.5M | 0.06% |
+1,517,800
| New | +$35.1M |
|
470
Northwest Bancshares
NWBI
$2.25B
| $35.5M | 0.06% |
1,966,700
+136,100
| +7% | +$2.32M |
|
471
Pilgrim's Pride
PPC
$6.94B
| $35.4M | 0.06% |
1,862,000
-802,713
| -30% | -$15.7M |
|
472
Consolidated Edison
ED
$41.1B
| $35.3M | 0.06% |
479,100
+373,900
| +355% | +$27M |
|
473
Owens Corning
OC
$11.6B
| $35.1M | 0.06% |
681,300
+435,500
| +177% | +$22.6M |
|
|
NMBL
474
DELISTED
Nimble Storage, Inc.
NMBL
| $35.1M | 0.06% |
4,433,700
-146,600
| -3% | -$1.19M |
|
475
Agilent Technologies
A
$38.9B
| $34.9M | 0.06% |
766,200
+753,800
| +6,079% | +$34.2M |
|
Similar funds
Renaissance Technologies's Q4 2016 Portfolio in Review
As of Q4 2016, Renaissance Technologies held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Renaissance Technologies deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Renaissance Technologies's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Renaissance Technologies's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Renaissance Technologies fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Renaissance Technologies's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Renaissance Technologies opened 418 new positions and closed 494 in Q4 2016.
- Renaissance Technologies's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.